Rich Pharmaceuticals, Inc.: 10-Q filed 2017-12-29
What Rich Pharmaceuticals, Inc. reported in its quarterly report filed 2017-12-29 (fiscal Q2 2018): 23 published measures, 58 facts as tagged in accession 0001662252-17-000254.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-12-29
- Fiscal period
- fiscal Q2 2018
- Accession
- 0001662252-17-000254 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Rich Pharmaceuticals, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 56,812 | USD | |
| At 2017-03-31 | 53,028 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 5,363,244 | USD | |
| At 2017-03-31 | 5,378,847 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -5,306,432 | USD | |
| At 2017-03-31 | -5,325,819 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 24,974 | USD | |
| At 2017-03-31 | 40,903 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 1,796,247 | USD | 92 |
| 2017-04-01 to 2017-09-30 | -505,637 | USD | 183 |
| 2016-07-01 to 2016-09-30 | -266,519 | USD | 92 |
| 2016-04-01 to 2016-09-30 | -444,883 | USD | 183 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | -293,893 | USD | 183 |
| 2016-04-01 to 2016-09-30 | -190,438 | USD | 183 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 115,000 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 115,000 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | 298,264 | USD | 183 |
| 2016-04-01 to 2016-09-30 | 190,438 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | -20,300 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -12,950,406 | USD | |
| At 2017-03-31 | -12,444,769 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 1,538 | USD | |
| At 2017-03-31 | 2,125 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -216,463 | USD | 92 |
| 2017-04-01 to 2017-09-30 | -687,938 | USD | 183 |
| 2016-07-01 to 2016-09-30 | -182,795 | USD | 92 |
| 2016-04-01 to 2016-09-30 | -398,272 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 40,274 | USD | |
| At 2017-03-31 | 50,903 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -121,909 | USD | 92 |
| 2017-04-01 to 2017-09-30 | -168,682 | USD | 183 |
| 2016-07-01 to 2016-09-30 | -109,466 | USD | 92 |
| 2016-04-01 to 2016-09-30 | -142,475 | USD | 183 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 5,363,244 | USD | |
| At 2017-03-31 | 5,378,847 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 312,134 | USD | |
| At 2017-03-31 | 296,635 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 331,463 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 802,938 | USD | 183 |
| 2016-07-01 to 2016-09-30 | 182,795 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 398,272 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 833 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 148,406 | USD | 183 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 6,657,296 | USD | |
| At 2017-03-31 | 7,011,504 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 1,188,520 | USD | |
| At 2017-03-31 | 937,783 | USD |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 313 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 586 | USD | 183 |
| 2016-04-01 to 2017-03-31 | 1,606 | USD | 365 |
| 2016-07-01 to 2016-09-30 | 431 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 863 | USD | 183 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 2,012,710 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 182,301 | USD | 183 |
| 2016-07-01 to 2016-09-30 | -83,724 | USD | 92 |
| 2016-04-01 to 2016-09-30 | -46,611 | USD | 183 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | 249,199 | USD | 183 |
| 2016-04-01 to 2016-09-30 | 111,299 | USD | 183 |
Inspect the source
- Entity
- Rich Pharmaceuticals, Inc. / CIK 0001504389
- Captured
- SEC response SHA-256
915b548928758b0cd7825b62d7fc36ff2ecd50f0e88985055b0b19ae94428b67
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001504389.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))